CGD is an inherited immunodeficiency characterized by a hyper-inflammatory response and an inability to produce reactive oxygen intermediates (ROI), which might lead to impaired counter-regulation by the IDO pathway and insufficient Nrf2 activation [32, 61]. Here, NFE2L2 is linked to chronic granulomatous disease.